Metropolis Healthcare Ltd (NSE:METROPOLIS)

₹ 2141.6 1.75 (0.08%) Market Cap: 109.83 Bil Enterprise Value: 109.82 Bil PE Ratio: 74.48 PB Ratio: 9.27 GF Score: 93/100

Q2 2025 Metropolis Healthcare Ltd Earnings Call Transcript
Nov 11, 2024

₹2154.8 (+1.86%)

Earnings
Q1 2025 Metropolis Healthcare Ltd Earnings Call Transcript
Aug 12, 2024

₹2038.65 (-0.94%)

Earnings
Q4 2024 Metropolis Healthcare Ltd Earnings Call Transcript
May 22, 2024

₹1956.05 (+2.80%)

Earnings
Q3 2024 Metropolis Healthcare Ltd Earnings Call Transcript
Feb 05, 2024

₹1666.8 (+1.80%)

Earnings
Q2 2024 Metropolis Healthcare Ltd Earnings Call Transcript
Nov 06, 2023

₹1571.55 (+6.73%)

Earnings
Q1 2024 Metropolis Healthcare Ltd Earnings Call Transcript
Aug 03, 2023

₹1407.65 (+2.89%)

Earnings
Q4 2023 Metropolis Healthcare Ltd Earnings Call Transcript
May 17, 2023

₹1296.65 (-0.90%)

Earnings
Q3 2023 Metropolis Healthcare Ltd Earnings Call Transcript
Feb 13, 2023

₹1312.5 (+2.00%)

Earnings
Q2 2021 Metropolis Healthcare Ltd Earnings Call Transcript
Nov 11, 2020

₹1891.5 (+1.59%)

Earnings
Q1 2021 Metropolis Healthcare Ltd Earnings Call Transcript
Aug 11, 2020

₹1605.6 (-6.27%)

Earnings
Q4 2020 Metropolis Healthcare Ltd Earnings Call Transcript
May 29, 2020

₹1384.95 (+4.77%)

Earnings

Q2 2024 Metropolis Healthcare Ltd Earnings Call Transcript

Nov 06, 2023 / 03:30AM GMT

Release Date Price: ₹1571.55 (+6.73%)

Transcript

Operator

Ladies and gentlemen, good day and welcome to the Q2 FY24 earnings conference call of Metropolis Healthcare Limited, hosted by Nuvama Institutional Equities.

This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as on the date of this call. These statements do not guarantee the future performance of the company, and it may involve risks and uncertainties that are difficult to predict.

(Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Aashita Jain from Nuvama Institutional Equities. Thank you, and over to you, Ms. Jain.

Aashita Jain

Nuvama Institutional Equities - Analyst

Thank you, Mishra, and good morning, everyone. On behalf of Nuvama Institutional Equities, I, Aashita Jain, welcome you all for Metropolis Q2 and H1 FY24 earnings call. With us, we have Metropolis Senior Management Team, represented by Ms. Ameera Shah, Managing Officer; Mr. Surendran Chemmenkotil, CEO; and Mr.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.